News

The LumaGEM Molecular Breast Imaging (MBI) business of Gamma Medica Inc. has been acquired through a chapter 11 sale by Imaging Acquisition Inc., an entity controlled by healthcare growth equity firm Psilos Group Managers LLC. Molecular breast imaging is an adjunct technology to mammography which radiologists use to help diagnose cancerous lesions in women with dense breast tissue. Already used in 15 prestigious medical institutions and clinical practices throughout the United States, the acquisition and investment by Psilos will enable the more focused company to meet the rapidly growing demand for LumaGEM.

Time March 25, 2013
Home
Videos | Cardiac PACS

McKesson highlighted enhancements to its cardiovascular information system (CVIS) version 13. The system offers new ...

Time March 22, 2013
Home
Blog

Only one radiological modality – mammography – is used today for screening. Yet, as America hurdles toward preventive medicine, screening is where it will be at. Now researchers in Cleveland are floating the idea of using MRI as a standard procedure in annual checkups.

Time March 22, 2013
Home
News

Virginia has amended its breast density inform law to include language in information given to patients explaining the risk of dense breast tissue. Originally signed into law by Gov. Bob McDonnell in 2012, the amendment strengthens the density notification to women and is modeled after laws in New York and California. The amendment to the law becomes effective July 1, 2013.

Time March 22, 2013
Home
News

The Medical Imaging and Technology Alliance (MITA), Advanced Medical Technology Association (AdvaMed) and the Medical Device Manufacturers Association (MDMA) applauded the adoption of an amendment to the Fiscal Year 2014 Senate Budget Resolution that expresses support for repeal of the medical device tax.

Time March 22, 2013
Home
News

A new report that breast cancer patients treated with low doses of radiation therapy have a heightened risk of heart disease suggests that physicians need to work with patients before, during, and after treatment to minimize that risk, according to an accompanying editorial in the March 14 issue of the New England Journal of Medicine.

Time March 22, 2013
Home
Technology

GE Healthcare announced the U.S. Food and Drug Administration (FDA) approval of a new indication for AdreView (Iobenguane I 123 Injection), the first and only FDA approved molecular imaging agent to link nerve function in the heart to a patient’s mortality risk.[1] AdreView is approved for the scintigraphic assessment of myocardial sympathetic innervation (cardiac nerve activity) to assist in the evaluation of patients with New York Heart Association (NYHA) Class II or Class III heart failure and left ventricular ejection fraction (LVEF) ? 35 percent.[2]

Time March 22, 2013
Home
News

Network security issues, vital infrastructure upgrades, electronic health record (EHR) implementation and impending federal deadlines will guide priorities this year, according to an independent research study of 100 healthcare provider CIOs and senior IT executives that was commissioned by Level 3 Communications Inc.

Time March 22, 2013
Home
News

Carestream was awarded 43 patents from the U.S. Patent and Trademark Office in 2012 for innovations in radiology imaging, healthcare IT, dental imaging and other areas, capping another strong year for technology development across its businesses. These new patents include: improvements in digital radiography detectors; advanced image processing techniques for digital radiography, mammography exams and specialty applications; and medical imaging advancements for use in intensive care units, orthopedics and mobile X-ray systems.

Time March 22, 2013
Home
News

Merge Healthcare Incorporated featured its iConnect Clinical Enterprise Platform at the HIMSS13 Interoperability Showcase and in Merge's booth at this year's HIMSS conference in New Orleans.

Time March 22, 2013
Home
Technology

Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (gadoterate meglumine), a gadolinium-based contrast agent (GBCA) indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (2 years of age and older) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.

Time March 22, 2013
Home
Technology

Carestream announced new measurement tools for chiropractic professionals that make its computer radiography (CR) systems with acquisition/mini-PACS (picture archive and communications system) software an even more attractive and efficient digital image capture and management solution. These systems can be purchased from Carestream or through their authorized Carestream dealers.

Time March 21, 2013
Home
News

Calgary Scientific Inc. has entered into a partnership with Clinisys, to develop electronic medical record (EMR) solutions for healthcare practitioners. The agreement between the two Alberta-based companies will see Calgary Scientific’s Health Canada and U.S. Food and Drug Administration (FDA) diagnostically-cleared medical imaging solution, ResolutionMD, integrated into Clinisys’s cloud-based EMR solution. The integration of powerful visualization, collaboration and mobile tools with the patient record helps clinics to realize many benefits including high quality diagnostics and improved workflows, resulting in a complete circle of care for healthcare practitioners and their patients.

Time March 21, 2013
Home
News

From athletes to individuals suffering from osteoporosis, bone fractures are usually the result of tiny cracks accumulating over time — invisible rivulets of damage that, when coalesced, lead to that painful break.

Time March 20, 2013
Home
News

Northwest Community Healthcare (NCH) is unveiling new imaging and lab results functionality for its mobile app, MyNCH, which allows NCH Medical Group patients to view their lab and imaging results with just the tap of a finger on their smartphone.

Time March 20, 2013
Home
Feature | Greg Freiherr

For many years mammographers have been saddled with low reimbursements. Recognizing this, women’s health advocates lobbied successfully last decade for higher rates for mammograms produced with digital equipment.

Time March 19, 2013
Home
Feature | By Raymond Tu, M.D., Steven Rothenberg, Riad Charafeddine, M.D., Theodore Williams, MA, RT, and Rory Grace

United Medical Center (UMC) is a non-profit, full-service community hospital serving Southeast Washington, D.C. and nearby Maryland communities. Though rich in African-American heritage, the community faces many economic challenges.

Time March 19, 2013
Home
Feature | Dave Fornell

In an era of healthcare reform and a push to meet appropriate use guidelines for tests, imaging and therapy amid declining reimbursements, there has been much discussion about implementation of clinical decision support (CDS) software. There is apprehension by some physicians who view CDS as technology telling doctors how to practice medicine. There are others in healthcare who are concerned about adding cost with the implementation of this software and how it will be updated based on the most current clinical data and practice guidelines. However, if implemented in a way where it is integrated with workflow and accepted by the physicians and hospital leadership, CDS has helped some hospitals meet appropriate use criteria and reduce unnecessary tests, which in turn helped reduce healthcare costs.

Time March 19, 2013
Home
Feature | Williette Nyanue

The benefits of computer-aided detection (CAD) for mammography images can be a polarizing topic for many radiologists. The technology has proven to be beneficial in detecting breast calcifications, and today’s CAD software has nearly perfect accuracy in detecting these calcifications. The software has also been noted to help inexperienced radiologists with detecting suspicious areas of breast tissue that may require special attention. However, CAD has not yet proven to be as accurate in its detection of tumors, and for radiologists with a more experienced eye, the software has not made itself as useful. CAD developers are making specific changes to the software that allows for increased visual clarity, context and medical history to make this technology more effective for radiologists across the board.

Time March 19, 2013
Home
Case Study | Hologic Inc.

Just weeks after implementing 3D mammography (breast tomosynthesis) in their practice, radiologists at Weinstein Imaging Associates found breast cancers in three patients that were not seen on the 2D images and the entire staff became instant believers in the new technology.

Time March 19, 2013
Home
Subscribe Now